ReviewFrontiers in immunology2019

Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy.

Brett Eugene Phillips et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.